Medspa Staffing & Salary Guide: RN Injector, NP, Aesthetician

Registered nurses performing injections (neuromodulator and filler administration under physician supervision or delegation) represent the highest-volume, most cost-sensitive hire in most practices. Market range: $55,000–$85,000 base salary in secondary markets; $70,000–$110,000 in major metros (NYC, LA, Miami, San Francisco). Compensation structure typically includes base salary plus commission (8–15% of injection revenue) or bonus pools. Experience matters sharply: a nurse with 3+ years of aesthetic-specific training and a book of regular clients commands 20–30% premium over entry-level. RN injectors with advanced skills (complex volumization, thread lifts, advanced toxin techniques) in high-cost markets can reach $120,000+. The labor shortage in nursing generally has tightened supply; many RNs now negotiate flexible scheduling and continuing-education budgets as non-monetary compensation. Turnover in this cohort remains elevated (25–35% annually in competitive markets), driven by burnout, low base salary relative to independent-contractor aesthetician earnings, and poaching by larger MSOs offering benefits and stability.

NPs and PAs licensed to perform aesthetic procedures independently (or under collaborative agreements, depending on state) command higher base compensation but face increasing supply pressure. Market range: $90,000–$140,000 in secondary markets; $120,000–$180,000+ in major metros. Unlike RN injectors, NP/PA compensation is less commission-driven; most practices offer 5–12% bonus on revenue above a threshold. The critical variable is state scope-of-practice law: NPs in states with full independent practice authority (California, New York, Texas) can command premium pay and often negotiate equity or profit-sharing. Conversely, NPs in restrictive states (requiring physician co-signature or supervision) are paid closer to RN injector rates. Supply of aesthetically trained NPs has increased substantially since 2020, compressing salaries in saturated markets. Many NPs now demand part-time or hybrid remote/in-clinic arrangements; practices offering this flexibility can retain talent at lower base rates. Credential inflation is real: practices increasingly require NPs to hold board certification in dermatology or aesthetic medicine, which narrows the candidate pool but justifies higher pay.

Licensed aestheticians (state-licensed skincare specialists) perform non-invasive treatments (facials, chemical peels, microneedling, laser hair removal, LED therapy) and often serve as patient educators and front-line revenue drivers. Market range: $35,000–$55,000 base in secondary markets; $45,000–$75,000 in major metros. Unlike injectors, aesthetician pay is heavily commission-based: 40–60% of treatment revenue is typical, with base salary functioning as a draw against commission. An aesthetician generating $150,000 in annual revenue (realistic for a full-time, skilled provider in a busy practice) might earn $60,000–$90,000 total compensation. Credential matters: aestheticians with advanced certifications (microneedling, laser safety, chemical peel specialization) or esthetics licenses (higher tier than basic aesthetician license in some states) command 15–25% premium. Geographic arbitrage is pronounced: a licensed aesthetician in Austin or Denver earns 20–30% less than an equivalent provider in Boston or Seattle, yet cost of living is substantially lower. Turnover in this role is high (30–40% annually) because aestheticians often view medspa work as a stepping stone to independent practice, salon ownership, or medical aesthetics training. Retention strategies (equity, profit-sharing, education budgets, clear advancement to injector training) are cost-effective.

Medical directors and supervising physicians represent a fixed overhead cost often underestimated in staffing budgets. Compensation: $150,000–$300,000+ depending on scope (part-time medical director vs. full-time owner-operator). Part-time medical directors (10–20 hours/week) typically earn $100,000–$200,000 annually; full-time clinical directors earn $200,000–$400,000+. The critical driver is regulatory burden: states with strict physician-supervision requirements (requiring on-site presence, chart review, or direct oversight of injections) force practices to employ or contract higher-cost physician time. Conversely, states permitting nurse-independent practice or loose collaborative agreements allow practices to minimize physician labor. Compliance staffing—dedicated RNs or administrative staff managing chart audits, consent documentation, adverse-event reporting, and state-board compliance—is increasingly necessary. Budget $40,000–$80,000 annually for a dedicated compliance coordinator in a multi-location group. This is not discretionary: regulatory bodies (state medical boards, FDA, state attorney general offices) are actively auditing scope-of-practice violations and documentation gaps. A single citation or license suspension costs far more than preventive compliance labor.

The medspa labor market is bifurcating. In secondary and tertiary markets, supply of trained aestheticians and RN injectors exceeds demand, keeping wages flat or declining in real terms. In major metros and affluent suburbs, supply is tight, and large MSOs (Skin Wellness Collective, Ethos, Nurx, and PE-backed roll-ups) are aggressively recruiting with sign-on bonuses ($5,000–$15,000 for experienced RN injectors), equity grants, and benefits packages that independent practices cannot match. This is compressing margins for single-location owners competing for talent. Simultaneously, the rise of injectable-focused practices and med spas has created a new tier of highly specialized, high-earning injectors who command $100,000–$150,000+ base plus significant commission, effectively pricing themselves out of reach for many practices. Telehealth and remote work are beginning to reshape geography: some NPs and PAs are now negotiating hybrid arrangements (2–3 days in-clinic, remainder remote chart review or consultation), which allows practices to tap talent outside their immediate metro area but introduces compliance complexity (state licensure, supervision, liability). Wage growth for RN injectors and aestheticians has outpaced inflation since 2022, driven by nursing shortages and increased demand for aesthetic services; expect continued upward pressure.

Establish a payroll dashboard tracking: base salary, commission/bonus, benefits cost (health insurance, retirement, continuing education), and fully loaded cost per FTE. Fully loaded cost is typically 1.25–1.35× base salary when benefits and payroll taxes are included. Compare your cost per injector FTE to revenue per injector: a healthy practice generates $250,000–$400,000 annual revenue per RN injector FTE; if your injector cost is >35% of that revenue, you are overpaying or underutilizing. For aestheticians, target $150,000–$250,000 revenue per FTE; if cost exceeds 40% of revenue, reassess. Peer benchmarking is difficult because most practices do not disclose payroll; use industry surveys (ASAPS, AACS, state cosmetology boards publish aggregate data), consult with practice brokers and MSO operators, and network with non-competing practices in adjacent markets. Document turnover cost: replacing an RN injector costs $15,000–$30,000 in recruiting, training, and lost productivity. A 30% annual turnover rate in a 5-person clinical team costs $22,500–$45,000 annually—equivalent to a full FTE. Retention investments (modest raises, flexible scheduling, education budgets) often pay for themselves within 12 months.